What is the appropriate workup for an axillary mass in a 35-year-old female?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Workup for Axillary Mass in 35-Year-Old Female

Begin with axillary ultrasound as the primary initial imaging modality, complemented by diagnostic mammography and/or digital breast tomosynthesis to evaluate for an underlying breast primary. 1

Initial Imaging Approach

The appropriate workup follows a structured algorithm based on the 2022 ACR Appropriateness Criteria for imaging of the axilla 1:

Primary Imaging: Axillary Ultrasound

Axillary ultrasound is the most appropriate first-line imaging test for evaluating a palpable axillary mass 1. This modality:

  • Distinguishes solid from cystic lesions
  • Characterizes lymph node morphology versus other masses
  • Identifies accessory breast tissue and associated lesions 2, 3
  • Enables immediate US-guided biopsy if suspicious features are present
  • Has no radiation exposure

Complementary Breast Imaging

Diagnostic mammography and/or digital breast tomosynthesis should be performed concurrently to evaluate for an underlying breast primary, as NCCN guidelines recommend evaluating the breast when axillary lymphadenopathy is present 1. This is critical because:

  • The most common malignant cause of axillary adenopathy is ipsilateral breast cancer 1
  • However, only 7% of axillary masses in women without breast cancer history prove malignant 1
  • DBT shows particular benefit in women ages 40-49 years for detecting occult breast primaries 1

Differential Diagnosis Considerations

At age 35, the differential diagnosis is broad 1:

Benign etiologies (most common):

  • Reactive lymphadenopathy (infectious/inflammatory)
  • Ectopic/accessory breast tissue with fibrocystic changes or fibroadenoma 2, 4, 3
  • Lipomas
  • Nerve sheath tumors

Malignant etiologies (less common but critical):

  • Metastatic breast cancer (most common if malignant)
  • Lymphoma
  • Other metastatic disease

Biopsy Indications

Perform US-guided core needle biopsy if:

  • Suspicious sonographic features are identified (irregular margins, loss of fatty hilum, increased vascularity, cortical thickening >3mm)
  • The mass cannot be definitively characterized as benign
  • Clinical concern persists despite benign-appearing imaging 4, 5

Core needle biopsy is preferred over fine needle aspiration for definitive tissue diagnosis 4.

What NOT to Do Initially

Do not start with:

  • FDG-PET/CT: Not beneficial as initial imaging because it has low yield for detecting occult primary malignancy without first confirming malignant etiology 1. Less than 1% of breast cancers present as isolated axillary adenopathy 1
  • CT chest/abdomen/pelvis: Not indicated unless systemic disease or chest wall involvement is suspected 1
  • Breast MRI: Reserved for problem-solving when US shows adenopathy of unknown primary and mammography is negative 1
  • Mammography alone: Insufficient as sole imaging test, though enlarged nodes may be visible on mediolateral oblique views 1

Clinical Pitfalls to Avoid

  1. Don't assume benign based on age alone: While malignancy risk increases with age (mean age 55 years for malignant vs. 43 years for benign pathology 5), malignancies including breast cancer can occur at age 35 4, 6

  2. Don't miss ectopic breast tissue: Accessory breast tissue is present in up to 6% of women and can develop fibroadenomas, fibrocystic changes, or even carcinoma 2, 4, 7. This can be mistaken for lymphadenopathy or other pathology 7

  3. Don't overlook contralateral breast: In cases of occult breast cancer presenting as axillary mass, 5 of 9 patients in one series had contralateral breast primaries 5

Follow-up Based on Initial Findings

If imaging shows benign features and biopsy confirms benign pathology:

  • Clinical follow-up or observation may be appropriate
  • Complete excision can be considered for symptomatic lesions or patient preference 4

If malignancy is confirmed:

  • Proceed with appropriate staging (may then include MRI, PET/CT)
  • Multidisciplinary tumor board discussion
  • Sentinel lymph node biopsy has replaced axillary lymph node dissection as standard for staging in most breast cancer scenarios 1

Related Questions

What is the appropriate evaluation and management for a patient in primary care who presents with a painful axillary mass and arm pain?
Can axillary masses be mistaken for lipomas (fatty deposits)?
What are the possible causes of left axillary lymphadenopathy?
How should an axillary cyst be evaluated and treated?
In a 34-year-old woman with a strong maternal family history of breast cancer and a golf-ball-sized lump in the right axilla, how does a malignant mass typically feel?
In an otherwise healthy patient who has gained weight and has no alarm features, does this argue against gastric malignancy?
What is the recommended dosing, route, and duration of diazepam for acute musculoskeletal spasm in adults?
How should I manage a 3‑month‑15‑day‑old infant who presents with fever, pharyngitis, normal examination, negative C‑reactive protein, MRI showing mild dilated subarachnoid space, and an unsuccessful lumbar puncture?
Is my mixed connective tissue disease, high speckled antinuclear antibody (ANA) titer, elevated ribonucleoprotein (RNP) antibodies, mildly elevated erythrocyte sedimentation rate (ESR), and elevated creatine kinase (CK) related to my persistent tonsillar swelling?
In an 8‑week‑old infant with pyloric muscle thickness of 1.6 mm, pyloric canal length of 1.6 cm, and transverse diameter of 1.2 cm, what is the appropriate management?
How should ketamine be administered as a continuous intravenous infusion for analgesia in adult patients, including indications, dosing, titration, duration, and monitoring?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.